SAFETY & HEALTH POLICY Avient Corporation believes that safety and health are the highest corporate priority. As a member of the American Chemistry Council, we have adopted Responsible Care® Guiding Principles and the Process Safety Management Practices to continuously guide our efforts to improve safety performance. Our practices reinforce these imperatives, and our commitment to excellence in safety and health is absolute.

A gate should be placed in a thick area, far from the thin wall sections; against a perpendicular wall to help prevent jetting and gate blush. If the material is shear-sensitive, consult the material data sheet or processing guide for instructions to set recovery time • The cooling time should only be 1–2 seconds longer than the screw recovery time, unless dictated by dimensional stability or part thickness Minimize Clamp Pressure This step is done to reduce the amount of energy used by the machine. • Reduce the clamp tonnage until flash is seen around the parting line, then increase the clamp tonnage by 5-10% Minimize Cycle Time • Mold Open/Close – Should be as fast as possible, without slamming, and still produce a nice fluid motion • Ejector Speed – As fast as possible, without influencing part quality • Ejector Stroke – Only stroke the ejectors as many times as needed to separate the part from the core - i.e. Design Guide 27 Blush Root cause: Injecting too quickly through the gate.

Specific drying temperatures and times can be found on the Technical Data Sheets for each individual product. If using a specialty overmolding grade, follow the coloring recommendations given on the individual product Technical Data Sheet.

Environmental, Health and Safety 4. MINE SAFETY DISCLOSURES PART II ITEM 5. SELECTED FINANCIAL DATA ITEM 7.

Animal Testing Policy AVIENT CORPORATION AND SUBSIDIARIES In the normal course of doing business, Avient is required to conduct testing to ensure the safety of its products. Avient is committed to replacing, reducing and refining the use of animal testing by applying the following practices: • Replace – Before any vertebrae testing, Avient will investigate the use of alternative methods and approaches, including use of data that is already publically available, computational toxicology models and read-across to available data for similar substances. • Reduce – Avient will only consider animal testing if it is a legal requirement, or to ensure the safety of our products, when no suitable alternatives are available.

MINE SAFETY DISCLOSURES Not applicable. Environmental, Health and Safety 4. SELECTED FINANCIAL DATA ITEM 7.

Operating Income $3,783 $4,100 2020PF 2021E Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition Previous Guidance Current Guidance $3,783 $4,300 2020PF 2021E $308 $360 2020PF 2021E $308 $410 2020PF 2021E $1.93 $2.40 2020PF 2021E $1.93 $2.80 2020PF 2021E (1) (1)(1) (1)(1) (1) (in millions) (in millions) 12 BALANCE SHEET • Deleveraging to 1.9x net debt to adjusted EBITDA by the end of 2021 • Driven by record adjusted EBITDA performance and strong free cash flow generation from asset light business • Future cash deployment: M&A, opportunistic share repurchases and balance sheet / continued leverage reduction 3.5x 2.7x 1.9x 2019PF 2020PF 2021E Net Debt / Adjusted EBITDA (1) (1) ($ in millions) 2021E Adjusted EBITDA 560$ Free Cash Flow 275$ Total Debt 1,860 Less: Cash (800) Net Debt 1,060$ 2021E Net Debt / Adjusted EBITDA 1.9x (1) Financial information is pro forma to include a full year of Clariant Masterbatch business acquisition SUSTAINABILITY • Most recent Sustainability report substantially expanded disclosure on key environmental and social topics. • Aligned with leading reporting frameworks – GRI, SASB, TCFD. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.

Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product. Data Protection.

Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

MINE SAFETY DISCLOSURES Not applicable. President and Chief Operating Officer, Ennis Traffic Safety Solutions (a traffic safety and infrastructure company) from June 2008 to July 2012. Environmental, Health and Safety 4.